Reuters logo
BRIEF-VBI Vaccines reports positive outcome from phase III pre-ind discussions with the FDA for hepatitis B vaccine, Sci-B-Vac
2017年6月19日 / 下午1点08分 / 5 个月前

BRIEF-VBI Vaccines reports positive outcome from phase III pre-ind discussions with the FDA for hepatitis B vaccine, Sci-B-Vac

June 19 (Reuters) - Vbi Vaccines Inc

* Vbi Vaccines reports positive outcome from phase III pre-ind discussions with the FDA for Hepatitis B vaccine, Sci-B-Vac(tm)

* VBI Vaccines - confirm initial ind for Sci-B-Va will not require any additional clinical studies to support pivotal, global phase III clinical program​

* Says ‍VBI plans to submit ind in second half of 2017, together with clinical trial applications for Europe and Canada​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below